article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

Amid President Donald Trump’s stated desire to sharply reduce drug prices on the US market, India has also proposed to supply generic medicines at between 20% and 25% of the current reference branded prices, for three years after originator patent expiry.

article thumbnail

Pathbreakers: The journey of first generics

Pharmaceutical Technology

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. However, business and other considerations may have an impact on how quickly a generic becomes available.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

Joy Polefrone, the executive director of the organization, says it aims to build a cluster of partners who are capable of manufacturing generic medicines. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9 million as part of the Build Back Better Regional Challenge.

article thumbnail

Public Health advocates call on policymakers to end drug shortages in the U.S.

Quality Matters

The policy recommendations therein aim to help prevent and mitigate shortages, ensuring that patients have access to the quality medicines they need when they need them. Both the Administration and Congress have given significant attention to this pervasive issue, as recognized in the recent white paper published by the U.S.